• August 14, 2009 at 2:02 pm

    Axona is Accera’s new product for people with mild to moderate Alzheimer’s. Available in the U.S. by prescription only, Axona is marketed as a medical food. This means it was not subject to FDA pre-market review and approval. Results of the company’s trials of Axona sound promising, but we’ll have to wait for more data to be published to get a better idea how effective the product is.
    You can read more about it here:


    Now this sounds promising….one drink a day to a clearer head!!!